NEW YORK (GenomeWeb) – GenomeDx today announced an agreement with Prime Health Services providing coverage of GenomeDx's prostate cancer test.

Under the terms of the deal, the test, called Decipher, will be covered by Prime Health for patients whose physicians order it. Prime Health's network includes 9 million covered lives and brings the total number of covered lives for Decipher to about 120 million, GenomeDx said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.